Transforming growth factor-beta (TGF-beta). The international journal of biochemistry & cell biology vol
Retatrutide vs Semaglutide and Tirzepatide Retatrutide, semaglutide, and tirzepatide are all long-acting GLP-1 receptor agonists or related receptor agonists used in obesity and type 2 diabetes management
Specific visual indicators of damage include particulate matter (floating particles or sediment), cloudiness or turbidity, color changes (darkening or unusual tints), crystallization, or separation of solution components
However, there is potential for more serious adverse effects, such as: 1 Vision problems Swelling in the extremities Dizziness or fainting Reduced urination Rash Rapid heart rate Swelling of the throat, tongue, mouth, face, or eyes Problems swallowing or breathing Fever Yellow eyes or skin Chronic upper stomach pain Wegovy, another brand name for semaglutide, may also cause damage to the retina, suicidal ideation, gallstones, pancreatitis, and acute kidney damage